Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs?

被引：0
|
作者：
Bianca Rocca
Giovanni Davì
机构：
[1] B Rocca is Adjunct Professor of Pharmacology at the 2nd Medical School of the University of Rome “La Sapienza”,
[2] and G Davì is Professor of Internal Medicine at the University of Chieti,undefined
[3] Italy.,undefined
来源：
Nature Clinical Practice Rheumatology | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：316 / 317
页数：1
相关论文
共 50 条
  • [1] Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs?
    Rocca, Bianca
    Davi, Giovanni
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (06): : 316 - 317
  • [2] Gastrointestinal safety of COX2 inhibitors might be no better than that of nonselective NSAIDs
    Rachel Murphy
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 (4): : 176 - 176
  • [3] Are COX-2 selective inhibitors safer than NSAIDs for patients with osteoarthritis and rheumatoid arthritis?
    Lanas, Angel
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (12): : 648 - 649
  • [4] Are COX-2 selective inhibitors safer than NSAIDs for patients with osteoarthritis and rheumatoid arthritis?
    Angel Lanas
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 : 648 - 649
  • [5] Vascular events with selective COX2 inhibitors and NSAIDs: analyzing the risks
    Brophy, James M.
    [J]. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (11): : 586 - 587
  • [6] Drug utilization, clinical and economic outcomes of patients with osteoarthritis of the hip and/or knee treated with long-term use of traditional NSAIDs, topical NSAIDs, and COX-2 inhibitors
    Silverman, Stewart L.
    Schepman, Patricia
    Rice, J. Bradford
    Beck, Craig G.
    Johnson, Michaela
    White, Alan
    Robinson, Rebecca L.
    Emir, Birol
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (07) : 1153 - 1166
  • [7] Vascular events with selective COX2 inhibitors and NSAIDs: analyzing the risks
    James M Brophy
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 586 - 587
  • [8] Use of NSAIDS and COX-2 inhibitors in osteoarthritis patients in Europe and the USA
    Piercy, J
    Turner, A
    Hird, A
    Karavali, M
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S78 - S78
  • [9] Value of Information in the Osteoarthritis SettingCost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
    Nicholas Latimer
    Joanne Lord
    Robert L. Grant
    Rachel O’Mahony
    John Dickson
    Philip G. Conaghan
    [J]. PharmacoEconomics, 2011, 29 : 225 - 237
  • [10] Value of Information in the Osteoarthritis Setting Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
    Latimer, Nicholas
    Lord, Joanne
    Grant, Robert L.
    O'Mahony, Rachel
    Dickson, John
    Conaghan, Philip G.
    [J]. PHARMACOECONOMICS, 2011, 29 (03) : 225 - 237
12345